|
|

This is only a preview of the paper Click here to register and get the full text. Existing members click here to login
|
|
|
Novo Nordisk manufactures and markets pharmaceutical products and services “that make a significant difference to patients, the medical profession and society”. The pharmaceutical industry has traditionally been a safe haven for investors, with consistent sales development and respectable growth in earnings that mirrored the increasing and widespread interest in the healthcare industry in recent years. Worldwide turnover for the pharmaceutical industry continued to rise in 2002, yet a number of companies had to adjust their growth expectations downward in the face of increasing pressure on prices and unexpected market developments.
Approximate Word count = 350 Approximate Pages = 1.4 (250 words per page double spaced)
|
|
|
|
|
|